(Revised 8/31/2018) A: PPS networks were submitted via the DSRIP Network Tool for the purposes of calculating attribution for valuation and later, attribution for performance
doi: 10.3389/fnagi.2025.1617106 Received 23 April 2025 Accepted 30 June 2025 Published 18 September 2025 Volume 17 - 2025 Edited by Francisco Navarrete, Miguel Hernndez University of Elche, Spain Reviewed by Robert Fekete, New York Medical College, United States Yutaka Oji, Juntendo University, Japan Updates Copyright 2025 Chaudhary, Chaudhary and Rawat
A Double-Blind Comparison of Clebopride and Placebo in Dyspepsia Secondary to Delayed Gastric Emptying
These factors, combined with robust clinical evidence demonstrating efficacy in glycemic control and weight management, ensure North America retains the largest market share for GLP-1 receptor agonists globally
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes